These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29035452)

  • 1. Role of Cytokines in the Pathogenesis of Visceral Leishmaniasis.
    Kumar R; Bhatia M; Pai K
    Clin Lab; 2017 Oct; 63(10):1549-1559. PubMed ID: 29035452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine saga in visceral leishmaniasis.
    Bhor R; Rafati S; Pai K
    Cytokine; 2021 Nov; 147():155322. PubMed ID: 33127259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses in kala-azar.
    Saha S; Mondal S; Banerjee A; Ghose J; Bhowmick S; Ali N
    Indian J Med Res; 2006 Mar; 123(3):245-66. PubMed ID: 16778308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis.
    Khatonier R; Ahmed G; Sarmah P; Narain K; Khan AM
    Immunobiology; 2021 Nov; 226(6):152148. PubMed ID: 34773853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.
    Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N
    J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic CD4+ T Cells in Progressive Visceral Leishmaniasis Show a Mixed Effector-Regulatory Phenotype and Impair Macrophage Effector Function through Inhibitory Receptor Expression.
    Medina-Colorado AA; Osorio EY; Saldarriaga OA; Travi BL; Kong F; Spratt H; Soong L; Melby PC
    PLoS One; 2017; 12(1):e0169496. PubMed ID: 28103263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis.
    Bhattacharya P; Ali N
    Rev Soc Bras Med Trop; 2013; 46(2):128-34. PubMed ID: 23559342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-27 (IL-27) Mediates Susceptibility to Visceral Leishmaniasis by Suppressing the IL-17-Neutrophil Response.
    Quirino GFS; Nascimento MSL; Davoli-Ferreira M; Sacramento LA; Lima MHF; Almeida RP; Carregaro V; Silva JS
    Infect Immun; 2016 Aug; 84(8):2289-2298. PubMed ID: 27245409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis.
    Mukherjee S; Mukhopadhyay D; Ghosh S; Barbhuiya JN; Das NK; Chatterjee M
    J Clin Immunol; 2016 Jan; 36(1):85-94. PubMed ID: 26644312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.
    Bhattacharya P; Ghosh S; Ejazi SA; Rahaman M; Pandey K; Ravi Das VN; Das P; Goswami RP; Saha B; Ali N
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004422. PubMed ID: 26829554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Treg, Breg and other cytokine sets in host protection and immunopathology during human leishmaniasis: Are they potential valuable markers in clinical settings and vaccine evaluation?
    Divenuto F; Pavia G; Marascio N; Barreca GS; Quirino A; Matera G
    Acta Trop; 2023 Apr; 240():106849. PubMed ID: 36731621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.
    Dayakar A; Chandrasekaran S; Kuchipudi SV; Kalangi SK
    Front Immunol; 2019; 10():670. PubMed ID: 31024534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.
    Banerjee A; Bhattacharya P; Joshi AB; Ismail N; Dey R; Nakhasi HL
    Cell Immunol; 2016 Nov; 309():37-41. PubMed ID: 27444130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Chemokines in the Pathogenesis of Visceral Leishmaniasis.
    Kumar R; Bhatia M; Pai K
    Curr Med Chem; 2022; 29(33):5441-5461. PubMed ID: 35579167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLA-PGN-primed dendritic cell-based vaccination induces Th17-mediated protective immunity against experimental visceral leishmaniasis: a crucial role of PKCβ.
    Jawed JJ; Majumder S; Bandyopadhyay S; Biswas S; Parveen S; Majumdar S
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27150838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.